INFARMED Leadership Appointments: A New Era in ...

By João L. Carapinha

January 6, 2026

INFARMED Leadership Appointments: Renewed Expertise for Medicines Oversight The Portuguese Council of Ministers has issued
Preparing for the EU Health Technology Assessment: Key Insights from the Upco...
Transforming EU Pharmaceutical Legislation: EMA’s Strategic Priorities ...
Strategic Avalere Health Appointments Enhance Leadership in Navigating US Hea...
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggress...
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare
Provisional Agreement on EU Pharmaceutical Reform: Boosting Innovation and Co...
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
Strengthening EU Pharmaceutical Supply Security Through the Critical Medicine...
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufac...
Medicare Drug Price Negotiations: Major Savings for Seniors on Cancer and Chr...
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Res...